Stable analogs of bioactive peptides containing disulfide linkages
AssigneeBioSynthema Inc.
InventorsRaghavan Rajagopalan, Ananthachari Srinivasan, Leon R. Lyle
Life of this patent
Estimating the term…
Loading patent…
AssigneeBioSynthema Inc.
InventorsRaghavan Rajagopalan, Ananthachari Srinivasan, Leon R. Lyle
Estimating the term…
Stable analogs of cyclic peptides containing disulfide linkages are disclosed. The disulfide linkage is modified by one of four methods: (a) sulfide contraction, (b) isosteric substitution, (c) thioketal expansion, or (d) alkylation expansion. In sulfide contraction the disulfide bond (—S—S—) is replaced with a monosulfide bond (—S—) in which a bifunctional effector molecule, such as a ligand or chemotoxic agent, is bound to the new peptide linkage. In isosteric substitution, one sulfur atom is replaced with a carbon atom and at least one of the carbon atoms at the modified site is a bifunctional effector molecule. In thioketal expansion, an alkylidene unit (—CR1C2—) is inserted between the two sulfur atoms. In alkylation expansion, an alkyl moiety of from C2 to C3, is inserted between the two sulfur atoms.
A cyclic peptide analog having the following general formula:
A cyclic peptide analog having the following general formula:
Dependencies are inferred from the claim text.